5F-NNE1
From Wikipedia, the free encyclopedia
Legal status | |
---|---|
Legal status |
|
Identifiers | |
|
|
CAS Number | 1445580-60-8 |
PubChem (CID) | 118796566 |
ChemSpider | 29341632 |
UNII | 3T22QDP4D9 |
Chemical and physical data | |
Formula | C24H23FN2O |
Molar mass | 374.45 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
5F-NNE1 (also known as 5F-NNEI and 5F-MN-24) is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1][2] Given the known metabolic liberation (and presence as an impurity) of amantadine in the related compound APINACA, it is suspected that metabolic hydrolysis of the amide group of 5F-NNE1 may release 1-naphthylamine, a known carcinogen.
Legality[edit]
Sweden's public health agency suggested classifying 5F-NNE1 as hazardous substance on November 10, 2014.[3]
See also[edit]
References[edit]
- ^ "5F-NNEI". Southern Association of Forensic Scientists. Retrieved 24 July 2015.
- ^ Ariane Wohlfarth; Marisol S. Castaneto; Mingshe Zhu; Shaokun Pang; Karl B. Scheidweiler; Robert Kronstrand; Marilyn A. Huestis (May 2015). "Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA". The AAPS Journal. 17 (3): 660–677. doi:10.1208/s12248-015-9721-0. PMC 4406957. PMID 25721194.
- ^ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Folkhälsomyndigheten. Retrieved 24 July 2015.
This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |